%0 Journal Article
%T A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes
%A Alin Stirban
%A Andreas Berk
%A Arne Terjung
%A Habib Esmaeili
%A Maximilian von Eynatten
%A Nikolaus Marx
%A Robert Chilton
%A Sandra Thiemann
%A Thomas Jax
%J Archive of "Cardiovascular Diabetology".
%D 2017
%R 10.1186/s12933-016-0493-3
%X Studies of dipeptidyl peptidase (DPP)-4 inhibitors report heterogeneous effects on endothelial function in patients with type 2 diabetes (T2D). This study assessed the effects of the DPP-4 inhibitor linagliptin versus the sulphonylurea glimepiride and placebo on measures of macro- and microvascular endothelial function in patients with T2D who represented a primary cardiovascular disease prevention population
%K Type 2 diabetes
%K Dipeptidyl peptidase-4 inhibitor
%K Linagliptin
%K Sulphonylurea
%K Endothelial function
%K Macrovascular
%K Microvascular
%K Flow-mediated vasodilation
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5251248/